Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Cancer. 2017 Oct 26;124(3):499–506. doi: 10.1002/cncr.31024

Table 1.

Demographic and Clinical Characteristics of the Sample

ADT+ (n = 78) ADT− (n = 99) CA− (n = 108) ADT+ vs. ADT− ADT+ vs. CA− ADT+ vs. All Controls

Characteristic Mean (SD) Mean (SD) Mean (SD) t (p) t (p) t (p)

Age, years 68.49 (8.52) 67.71 (7.46) 67.80 (11.93) 0.65 (.52) 0.46 (.65) 0.57 (.57)

Years since diagnosis 4.01 (5.08) 4.69 (4.53) - −0.91 (.37) - -

Body mass index, kg/m2 28.29 (4.04) 29.30 (4.12) 29.65 (5.19) −1.42 (.16) −1.73 (.09) −1.70 (.09)

Comorbidity index score 2.86 (1.11) 2.38 (0.80) 2.68 (1.06) 3.17 (.002) 1.13 (.26) 2.43 (.02)

Characteristic No. (%) No. (%) No. (%) χ2 (p) χ2 (p) χ2 (p)

Education, years 7.32 (.03) 8.47 (.01) 10.69 (.005)
 ≤ 12 32 (41%) 22 (22%) 23 (21%)
 13 – 16 36 (46%) 59 (60%) 67 (62%)
 ≥ 17 10 (13%) 18 (18%) 18 (17%)

Race 2.42 (.12) 4.10 (.04) 4.68 (.03)
 White 68 (87%) 93 (94%) 103 (95%)
 Nonwhite 10 (13%) 6 (6%) 5 (5%)

Ethnicity (.99) (.53) (.99)
 Non-Hispanic 74 (95%) 95 (96%) 101 (94%)
 Hispanic 3 (4%) 3 (3%) 7 (6%)
 Missing 1 (1%) 1 (1%) 0 (0%)

Gleason score (< .001) - -
 4–6 12 (15%) 31 (31%) -
 7 17 (22%) 26 (26%) -
 8 18 (23%) 2 (2%) -
 9–10 8 (10%) 0 (0%) -
 Missing 23 (30%) 40 (40%) -

Note. ADT+ = prostate cancer patients treated with ADT; ADT− = prostate cancer patients not treated with ADT; CA− = men with no history of prostate cancer; SD = standard deviation. p values calculated using t-tests for continuous variables and χ2 tests or Fisher’s exact tests for categorical variables. Missing values were excluded from analyses. In analyses with cell sizes ≤ 5, p values were calculated using Fisher’s exact test which yields no test statistic.